Testing a wearable electric field device for cancer in the spine lining
Original title: Tumor Treating Fields for the Treatment of Leptomeningeal Metastases of the Spine in Patients With Breast or Lung Cancer
How far along is this research?
This is a trial that is enrolling or has been updated. It is not a finding yet.
No phase is listed, and this is still an early test of safety in people.
Status: Recruiting. It is looking for patients now. Talk to your care team about whether it fits you.
The trial team last updated this record on . Always check the trial page for the latest.
The short version
This trial tests a device worn on the body that uses electric fields to try to stop tumor cells from growing.
Who this trial is for. This trial is for people with breast or lung cancer that has spread from where it started to other parts of the body. It tests a portable device, the Novo TTF-200T, for cancer in the lining around the spine.
Where it stands. This trial has not reported results. It is looking at whether the device is safe and whether people can use it. The answer is not in yet.
What this means, and what it doesn't
What it could mean: Nothing here shows the device helps. The team hopes what they learn will lead to better treatment later. Someone who fits this trial could ask their care team about it.
What it doesn't mean: This does not mean the device works. A trial is a test, not a proven treatment. Being in one is not a guarantee of benefit. It is not a promise of a cure.
Source: ClinicalTrials.gov, October 30, 2026 · Read the original
This plain-language summary was written by AI and published automatically after passing our automatic safety checks. How we write.